Additionally, individuals with Li–Fraumeni and FAMMM syndromes, carrying TP53 and CDKN2A mutations respectively, are commonly found to develop cancers in which the remaining tumour suppressor gene copy is lost [70,71]. This evidence concerns the gene CDKN2A and cancer.